HomeCompareGBIO vs MO

GBIO vs MO: Dividend Comparison 2026

GBIO yields 37.45% · MO yields 6.27%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 GBIO wins by $123.9K in total portfolio value
10 years
GBIO
GBIO
● Live price
37.45%
Share price
$5.34
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$201.6K
Annual income
$32,248.55
Full GBIO calculator →
MO
Altria Group Inc.
● Live price
6.27%
Share price
$67.02
Annual div
$4.20
5Y div CAGR
22.6%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$77.7K
Annual income
$28,968.54
Full MO calculator →

Portfolio growth — GBIO vs MO

📍 GBIO pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodGBIOMO
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, GBIO + MO cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
GBIO pays
MO pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

GBIO
Annual income on $10K today (after 15% tax)
$3,183.52/yr
After 10yr DRIP, annual income (after tax)
$27,411.27/yr
MO
Annual income on $10K today (after 15% tax)
$532.68/yr
After 10yr DRIP, annual income (after tax)
$24,623.26/yr
At 15% tax rate, GBIO beats the other by $2,788.01/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of GBIO + MO for your $10,000?

GBIO: 50%MO: 50%
100% MO50/50100% GBIO
Portfolio after 10yr
$139.7K
Annual income
$30,608.54/yr
Blended yield
21.92%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on MO right now

GBIO
Analyst Ratings
5
Buy
5
Hold
Consensus: Buy
Price Target
$5.25
-1.7% upside vs current
Range: $5.00 — $5.50
Altman Z
-9.1
Piotroski
1/9
MO
Analyst Ratings
16
Buy
9
Hold
1
Sell
Consensus: Buy
Price Target
$61.25
-8.6% upside vs current
Range: $47.00 — $68.00
Altman Z
3.2
Piotroski
7/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

GBIO buys
0
MO buys
11
PoliticianChamberTickerTypeAmountDate
Ro Khanna🏢 House$MO▲ Buy$1,000 - $15,0002025-08-04
Sheri Biggs🏢 House$MO▼ Sell$1,001 - $15,0002025-03-19
Pete Sessions🏢 House$MO▼ Sell$1,001 - $15,0002024-09-10
Ro Khanna🏢 House$MO▲ Buy$1,001 - $15,0002024-03-20
Ro Khanna🏢 House$MO▲ Buy$1,001 - $15,0002024-02-13
Virginia Foxx🏢 House$MO▼ Sell$1,001 - $15,0002024-01-16
Virginia Foxx🏢 House$MO▲ Buy$1,001 - $15,0002024-01-11
Ro Khanna🏢 House$MO▼ Sell$1,001 - $15,0002024-01-10
Ro Khanna🏢 House$MO▲ Buy$1,001 - $15,0002024-01-10
Virginia Foxx🏢 House$MO▼ Sell$15,001 - $50,0002024-01-10
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricGBIOMO
Forward yield37.45%6.27%
Annual dividend / share$2.00$4.20
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%22.6%
Portfolio after 10y$201.6K$77.7K
Annual income after 10y$32,248.55$28,968.54
Total dividends collected$148.7K$72.0K
Payment frequencyquarterlyquarterly
SectorStockConsumer Staples
Analyst consensusBuyBuy
Analyst price target$5.25$61.25

Year-by-year: GBIO vs MO ($10,000, DRIP)

YearGBIO PortfolioGBIO Income/yrMO PortfolioMO Income/yrGap
1← crossover$14,445$3,745.32$10,558$768.31+$3.9KGBIO
2$20,513$5,056.29$11,352$1,015.87+$9.2KGBIO
3$28,659$6,710.36$12,482$1,367.86+$16.2KGBIO
4$39,427$8,761.91$14,103$1,883.39+$25.3KGBIO
5$53,452$11,265.44$16,472$2,664.91+$37.0KGBIO
6$71,468$14,273.72$20,024$3,897.79+$51.4KGBIO
7$94,307$17,835.96$25,537$5,933.74+$68.8KGBIO
8$122,904$21,996.02$34,478$9,476.77+$88.4KGBIO
9$158,298$26,790.73$49,776$16,022.63+$108.5KGBIO
10$201,627$32,248.55$77,699$28,968.54+$123.9KGBIO

GBIO vs MO: Complete Analysis 2026

GBIOStock

Generation Bio Co., a genetic medicines company, develops therapies for the treatment of rare and prevalent diseases. The company provides a portfolio of programs, including programs for rare and prevalent diseases of the liver and retina. It also focuses on the diseases of skeletal muscle, central nervous system, and oncology. The company was formerly known as Torus Therapeutics, Inc. and changed its name to Generation Bio Co. in November 2017. Generation Bio Co. was incorporated in 2016 and is headquartered in Cambridge, Massachusetts.

Full GBIO Calculator →

MOConsumer Staples

Altria Group, Inc., through its subsidiaries, manufactures and sells smokeable and oral tobacco products in the United States. The company provides cigarettes primarily under the Marlboro brand; cigars and pipe tobacco principally under the Black & Mild brand; and moist smokeless tobacco products under the Copenhagen, Skoal, Red Seal, and Husky brands, as well as provides on! oral nicotine pouches. It sells its tobacco products primarily to wholesalers, including distributors; and large retail organizations, such as chain stores. Altria Group, Inc. was founded in 1822 and is headquartered in Richmond, Virginia.

Full MO Calculator →
📬

Get this GBIO vs MO comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

GBIO vs SCHDGBIO vs JEPIGBIO vs OGBIO vs KOGBIO vs MAINGBIO vs PMGBIO vs BTIGBIO vs PG

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.